National Pension Service Boosts Position in Stryker Corporation $SYK

National Pension Service boosted its position in shares of Stryker Corporation (NYSE:SYK) by 3.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 706,367 shares of the medical technology company’s stock after purchasing an additional 22,500 shares during the quarter. National Pension Service’s holdings in Stryker were worth $248,267,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Godfrey Financial Associates Inc. purchased a new stake in Stryker during the fourth quarter worth $26,000. United Financial Planning Group LLC purchased a new stake in Stryker during the third quarter worth $27,000. Strive Asset Management LLC purchased a new stake in Stryker during the third quarter worth $30,000. CGC Financial Services LLC purchased a new stake in Stryker during the fourth quarter worth $29,000. Finally, ANTIPODES PARTNERS Ltd purchased a new stake in shares of Stryker in the third quarter valued at $34,000. 77.09% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Stryker news, Director Ronda E. Stryker sold 310,000 shares of the company’s stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $312.23, for a total transaction of $96,791,300.00. Following the completion of the sale, the director directly owned 1,924,880 shares in the company, valued at $601,005,282.40. This represents a 13.87% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, VP M Kathryn Fink sold 3,500 shares of the company’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $283.45, for a total value of $992,075.00. Following the sale, the vice president owned 177 shares of the company’s stock, valued at $50,170.65. This represents a 95.19% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 323,264 shares of company stock worth $100,659,489 over the last three months. 4.60% of the stock is owned by insiders.

Stryker Stock Performance

Stryker stock opened at $305.73 on Friday. The firm has a market capitalization of $117.21 billion, a P/E ratio of 35.39, a PEG ratio of 1.94 and a beta of 0.80. The company has a current ratio of 2.11, a quick ratio of 1.25 and a debt-to-equity ratio of 0.62. The stock has a fifty day moving average price of $321.82 and a 200 day moving average price of $348.15. Stryker Corporation has a 52 week low of $281.00 and a 52 week high of $404.87.

Stryker (NYSE:SYK) last announced its quarterly earnings results on Thursday, April 30th. The medical technology company reported $2.60 EPS for the quarter, missing the consensus estimate of $2.98 by ($0.38). The firm had revenue of $6.02 billion for the quarter, compared to analyst estimates of $6.34 billion. Stryker had a return on equity of 23.42% and a net margin of 13.20%.The business’s revenue was up 2.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.84 earnings per share. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Equities research analysts anticipate that Stryker Corporation will post 14.98 earnings per share for the current year.

Stryker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be paid a dividend of $0.88 per share. The ex-dividend date is Tuesday, June 30th. This represents a $3.52 annualized dividend and a yield of 1.2%. Stryker’s dividend payout ratio is currently 40.74%.

Analyst Ratings Changes

Several analysts have recently issued reports on SYK shares. Sanford C. Bernstein set a $410.00 price objective on Stryker in a research report on Friday, May 1st. Weiss Ratings downgraded Stryker from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, May 4th. Leerink Partners started coverage on Stryker in a research report on Monday, April 13th. They issued an “outperform” rating and a $410.00 price objective on the stock. UBS Group reduced their price objective on Stryker from $400.00 to $380.00 and set a “neutral” rating on the stock in a research report on Tuesday, March 17th. Finally, William Blair restated an “outperform” rating on shares of Stryker in a research report on Thursday, March 5th. Sixteen equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $395.48.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.